ArticleJournal of cancer research and clinical oncology2026

Predictors of response and survival in cemiplimab-treated cutaneous squamous cell carcinoma: multicenter real-world evidence from Germany.

Thilo Gambichler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.